Malin Corporation | MLC - Des Atouts

Prix De L'Action
7.95
Variation Quotidienne
0 0%
Mensuellement
3.25%
Annuel
-6.47%
Q2 Prévisions
7.71




Des Atouts Changement Date
Akebia Therapeutics USD 376.56M 12.41M 2025-12
Alaunos Therapeutics USD 3.72M 1.01M 2025-09
ALKERMES USD 2.49B 157.48M 2025-12
Avita Medical AUD 56.39M 1.74M 2025-12
Dianthus Therapeutics USD 530.92M 46.52M 2025-12
Eurofins Scientific SE EUR 10.99B 399.1M 2025-12
Ionis Pharmaceuticals USD 3.52B 490.91M 2025-12
IQVIA Holdings USD 29.94B 1.22B 2025-12
Lonza CHF 18.97B 164M 2025-12
Malin Corporation EUR 198.5M 70.1M 2024-12
Moderna USD 12.34B 203M 2025-12
Organon & Co USD 13.55B 52M 2025-09
Ovoca Bio EUR 1.66M 9.75M 2025-06
Revvity USD 12.17B 29.46M 2025-12
Tectonic Therapeutic USD 261.04M 15.96M 2025-12
Viatris USD 37.19B 727.3M 2025-12
Xeris Pharmaceuticals USD 383.53M 13.34M 2025-12